Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.91% |
| 2 | Technology | 7.43% |
| 3 | Financials | 6.52% |
| 4 | Consumer Discretionary | 5.69% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUTL
1351
Autolus Therapeutics
AUTL
$623M
| $4.69M | 0.01% |
783,164
+106,683
| +16% | +$986K |
|
1352
CALL
HCA Healthcare
HCA
$92.9B
| $4.68M | 0.01% |
52,100
| – | – |
|
1353
Tetra Tech
TTEK
$9.44B
| $4.67M | 0.01% |
+330,395
| New | +$5.63M |
|
|
NXGN
1354
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $4.66M | 0.01% |
+446,632
| New | +$5.76M |
|
|
EPZM
1355
DELISTED
Epizyme, Inc
EPZM
| $4.66M | 0.01% |
300,646
+288,037
| +2,284% | +$6.19M |
|
|
ISEE
1356
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $4.64M | 0.01% |
1,348,500
+474,633
| +54% | +$2.77M |
|
|
MZTI
1357
The Marzetti Company
MZTI
$3.17B
| $4.63M | 0.01% |
+31,976
| New | +$4.85M |
|
1358
Radian Group
RDN
$4.86B
| $4.62M | 0.01% |
356,565
+164,677
| +86% | +$3.6M |
|
1359
PUT
Oneok
OKE
$58.6B
| $4.61M | 0.01% |
211,500
-800
| -0.4% | -$48.8K |
|
1360
Schneider National
SNDR
$6.11B
| $4.61M | 0.01% |
238,487
-838,793
| -78% | -$17.4M |
|
1361
Criteo S.A.
CRTO
$837M
| $4.6M | 0.01% |
578,534
+326,061
| +129% | +$4.16M |
|
1362
Minerva Neurosciences
NERV
$230M
| $4.6M | 0.01% |
95,443
-6,734
| -7% | -$406K |
|
1363
AudioCodes
AUDC
$232M
| $4.6M | 0.01% |
192,378
+138,359
| +256% | +$3.21M |
|
|
GLOG
1364
DELISTED
GASLOG LTD
GLOG
| $4.59M | 0.01% |
1,267,167
+951,155
| +301% | +$5.8M |
|
|
SBNY
1365
DELISTED
Signature Bank
SBNY
| $4.58M | 0.01% |
57,029
+50,654
| +795% | +$6.36M |
|
1366
TripAdvisor
TRIP
$1.19B
| $4.58M | 0.01% |
263,514
+210,039
| +393% | +$5.32M |
|
1367
FTI Consulting
FCN
$4.29B
| $4.58M | 0.01% |
38,255
-21,656
| -36% | -$2.55M |
|
|
CPAAW
1368
CALL
DELISTED
Conyers Park II Acquisition Corp. Warrant
CPAAW
| $4.58M | 0.01% |
+462,500
| New | +$858K |
|
1369
Brink's
BCO
$4.65B
| $4.57M | 0.01% |
87,762
+75,877
| +638% | +$5.93M |
|
1370
Interparfums
IPAR
$3.74B
| $4.55M | 0.01% |
98,252
+29,242
| +42% | +$1.83M |
|
|
RAVN
1371
DELISTED
Raven Industries Inc
RAVN
| $4.55M | 0.01% |
214,166
-71,282
| -25% | -$2.09M |
|
1372
State Street Energy Select Sector SPDR ETF
XLE
$41.5B
| $4.55M | 0.01% |
312,888
-263,596
| -46% | -$6.25M |
|
1373
Jazz Pharmaceuticals
JAZZ
$16.5B
| $4.53M | 0.01% |
45,433
-332
| -0.7% | -$42.9K |
|
|
DCOM
1374
DELISTED
Dime Community Bancshares
DCOM
| $4.53M | 0.01% |
330,281
-16,387
| -5% | -$291K |
|
1375
MillerKnoll
MLKN
$1.58B
| $4.53M | 0.01% |
203,902
+196,594
| +2,690% | +$6.8M |
|
Similar funds
Israel Englander's Q1 2020 Portfolio in Review
As of Q1 2020, Israel Englander held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Danaher worth $133M.
- Israel Englander's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Israel Englander added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Israel Englander's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Israel Englander fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Israel Englander opened 789 new positions and closed 1,154 in Q1 2020.
- Israel Englander's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.